ALS Expanded Access Research
AI summary
This funding opportunity supports research using expanded access data for investigational therapies in intermediate-sized populations of amyotrophic lateral sclerosis patients.
Generated by AI from the funder’s public info. Double-check details before applying.
What this grant funds
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific…
Who is eligible
- Federally recognized Native American tribal governments
- County governments
- State governments
- Special district governments
- Public and Indian housing authorities
- And 10 more applicant types (see More federal details)
Three steps to apply
Register in SAM.gov and Grants.gov. Federal applications need a UEI and an active SAM.gov registration. Registration can take several weeks.
Register in SAM.gov and Grants.gov
Federal applications need a UEI and an active SAM.gov registration. Registration can take several weeks.
Read the full announcement
Opportunity RFA-NS-26-001. It lists eligibility, budget rules and review criteria.
Submit on Grants.gov before the close date
Applications are due Nov 10, 2026.
Who’s behind it
Part of the Department of Health and Human Services. Federal grant-making agency listed on Grants.gov.
- Type
- Federal government
National Institutes of Health
Federal governmentMore federal details
Status, funding, applicant types, documents and assistance listings from the official listing.
Status & key dates
- ForecastNot forecast first
- PostedMay 4, 2026
- ClosesNov 10, 2026
- ArchiveJan 10, 2027
Funding
Eligible applicant types
Government
- Federally recognized Native American tribal governments
- County governments
- State governments
- Special district governments
- Public and Indian housing authorities
- City or township governments
Nonprofit
- Other Native American tribal organizations
- Nonprofits without 501(c)(3) status
- Nonprofits with 501(c)(3) status
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Business
- Small businesses
- For-profit organizations other than small businesses
Other
- Other (see additional eligibility)
Additional eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Eligible applicants must be clinical trial sites that participate in a phase 2/3 or phase 3 efficacy clinical trial (designed to provide pivotal data to support a marketing application) supported by a small business concern that is the FDA-designated sponsor of a drug or biological product which is the subject of an IND under section 505(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(i)) to prevent, diagnose, mitigate, treat, or cure ALS. The definition of a small business concern can be found in section 3(a) of the Small Business Act (15 U.S.C. 632(a)).Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Agency contact
Assistance listings
Source: Simpler.Grants.gov listing, version 1 · checked Nov 20, 2026
More from National Institutes of Health
Keep every grant in one place
Save grants, track deadlines and get reminders.